AMD invests $20M in drug-discovery company Absci, which will move toward greater use of AMD's GPUs; Absci has 470+ AI chips, most of which are from Nvidia (Belle Lin/Wall Street Journal)


Belle Lin / Wall Street Journal:

AMD invests $20M in drug-discovery company Absci, which will move toward greater use of AMD’s GPUs; Absci has 470+ AI chips, most of which are from Nvidia  —  The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries

Related Content

A US judge rules that Google must face a class action claiming Google collected users' personal data from their phones after switching off Web & App Activity (Jonathan Stempel/Reuters)

Video editing app Captions switches to a freemium model to boost growth

Decentralized payments startup Nevermined raises $4M to unlock AI-to-AI agent commerce

Leave a Comment